↓ Skip to main content

Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center

Overview of attention for article published in Supportive Care in Cancer, May 2008
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#24 of 5,122)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
1 news outlet
twitter
114 X users
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
92 Dimensions

Readers on

mendeley
80 Mendeley
Title
Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center
Published in
Supportive Care in Cancer, May 2008
DOI 10.1007/s00520-008-0459-4
Pubmed ID
Authors

Ahmed Elsayem, Eardie Curry III, Jeanette Boohene, Mark F. Munsell, Bianca Calderon, Frank Hung, Eduardo Bruera

Abstract

There is wide variation in the frequency of reported use of palliative sedation (PS) to control intractable and refractory symptoms in terminally ill patients. The aim of this study was to determine the frequency and outcomes of PS use and examine patterns of practice after establishment of a policy for the administration of midazolam for PS in our palliative care unit (PCU).

X Demographics

X Demographics

The data shown below were collected from the profiles of 114 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 1%
Austria 1 1%
United Kingdom 1 1%
Canada 1 1%
Spain 1 1%
Unknown 75 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 21%
Researcher 10 13%
Student > Bachelor 7 9%
Student > Postgraduate 6 8%
Student > Doctoral Student 5 6%
Other 18 23%
Unknown 17 21%
Readers by discipline Count As %
Medicine and Dentistry 44 55%
Nursing and Health Professions 8 10%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Agricultural and Biological Sciences 3 4%
Psychology 2 3%
Other 3 4%
Unknown 17 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 82. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2020.
All research outputs
#529,377
of 25,754,670 outputs
Outputs from Supportive Care in Cancer
#24
of 5,122 outputs
Outputs of similar age
#905
of 88,089 outputs
Outputs of similar age from Supportive Care in Cancer
#1
of 12 outputs
Altmetric has tracked 25,754,670 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,122 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 88,089 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.